Hebeda Dave 4
4 · Sagent Pharmaceuticals, Inc. · Filed Feb 24, 2012
Insider Transaction Report
Form 4
Hebeda Dave
Vice President, Finance
Transactions
- Award
Stock Option to Buy
2012-02-22+4,380→ 4,380 totalExercise: $22.04Exp: 2022-02-22→ Common Stock (4,380 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on February 22, 2013.